The broad goal of this work is to learn how gene expression is controlled in myeloma cells and how the genetic program at this terminal stage of differentiation is established over the course of B lymphocyte development. A specific goal of the present proposal is to determine how the immunoglobulin heavy chain gene enhancer operates in early (pre-B) and late-stage (myeloma) B lymphocytes. We will also use analysis of a spontaneously-derived myeloma variant (LP1) as a means for exploring how post-transcriptional processes contribute to stage-specific differences in IgH gene expression, as well. Our previous studies have shown that the constitutive, high level expression of IgH genes in myeloma cells can be maintained in the absence of the IgH enhancer. This has prompted us to propose an """"""""establishment-only"""""""" model of enhancer function in these cells. This model suggests that the enhancer can introduce a stable change in a gene so that the enhancer becomes superfluous to the gene's continued transcription. An alternate explanation for these results is that additional enhancer(s) flank the IgH locus, substituting for the IgH enhancer when it has been deleted. In the pre-B cell, we have shown that an exogenously-provided IgH gene requires the enhancer both to establish its expression and to maintain it through successive cell generations. The difference between the results in pre-B cells and those with endogenous genes in myeloma cells may reflect differences between transfected and endogenous IgH genes or between pre-B and myeloma cells, or both. We will use the method of gene replacement by homologous recombination to test the """"""""stable change"""""""" hypothesis. these experiments, it will be determined whether such a change can be effected in early stage lymphocytes and/or in transfected genes. Should the """"""""flanking enhancer"""""""" model be favored by the results obtained, experiments will be undertaken to determine whether they are tissue-specific and what role they play in normal B lymphocyte development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI030653-01
Application #
3145729
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1990-05-01
Project End
1995-04-30
Budget Start
1990-05-01
Budget End
1991-04-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Other Domestic Higher Education
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Peng, Cheng; Eckhardt, Laurel A (2013) Role of the Igh intronic enhancer E? in clonal selection at the pre-B to immature B cell transition. J Immunol 191:4399-411
Yan, Yi; Pieretti, Joyce; Ju, Zhongliang et al. (2011) Homologous elements hs3a and hs3b in the 3' regulatory region of the murine immunoglobulin heavy chain (Igh) locus are both dispensable for class-switch recombination. J Biol Chem 286:27123-31
Li, Fubin; Yan, Yi; Pieretti, Joyce et al. (2010) Comparison of identical and functional Igh alleles reveals a nonessential role for Eýý in somatic hypermutation and class-switch recombination. J Immunol 185:6049-57
Li, Fubin; Eckhardt, Laurel A (2009) A role for the IgH intronic enhancer E mu in enforcing allelic exclusion. J Exp Med 206:153-67
Zhang, Buyi; Alaie-Petrillo, Adrienne; Kon, Maria et al. (2007) Transcription of a productively rearranged Ig VDJC alpha does not require the presence of HS4 in the IgH 3'regulatory region. J Immunol 178:6297-306
Yan, Yi; Park, Sung Sup; Janz, Siegfried et al. (2007) In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3'regulatory region induces MYC expression at the immature stage of B cell development. Genes Chromosomes Cancer 46:950-9
Garrett, Francine E; Emelyanov, Alexander V; Sepulveda, Manuel A et al. (2005) Chromatin architecture near a potential 3' end of the igh locus involves modular regulation of histone modifications during B-Cell development and in vivo occupancy at CTCF sites. Mol Cell Biol 25:1511-25
Shi, X; Eckhardt, L A (2001) Deletional analyses reveal an essential role for the hs3b/hs4 IgH 3' enhancer pair in an Ig-secreting but not an earlier-stage B cell line. Int Immunol 13:1003-12
Stevens, S; Ong, J; Kim, U et al. (2000) Role of OCA-B in 3'-IgH enhancer function. J Immunol 164:5306-12
Ong, J; Stevens, S; Roeder, R G et al. (1998) 3' IgH enhancer elements shift synergistic interactions during B cell development. J Immunol 160:4896-903

Showing the most recent 10 out of 12 publications